Concourse Financial Group Securities, Inc. Molecular Templates, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.39 - $0.54 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$0.33 - $0.58 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$0.33 - $12.0 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$0.68 - $11.25 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$0.81 - $3.43 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$2.27 - $4.13 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	SELL	$3.37 - $6.87 $5,830 - $11,885	-1,730 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$5.78 - $7.86 $3,606 - $4,904	-624 Reduced 26.51%	1,730 $12,000
Q2 2021 Aug 13, 2021	SELL	$7.82 - $12.44 $23,694 - $37,693	-3,030 Reduced 56.28%	2,354 $18,000
Q1 2021 May 13, 2021	BUY	$9.33 - $14.05 $49,299 - $74,240	5,284 Added 5284.0%	5,384 $68,000
Q4 2020 Feb 02, 2021	BUY	$8.48 - $12.23 $848 - $1,223	100 New	100 $1,000
Q3 2020 Nov 13, 2020	BUY	$9.99 - $14.41 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.28 - $17.63 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$11.31 - $18.26 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$4.6 - $8.46 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$5.83 - $8.42 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$4.02 - $5.81 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.35 - $5.68 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$4.07 - $6.25 $0 - $0	0 New	0 $0

Others Institutions Holding MTEM

# of Institutions

Shares Held

499K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

299K
Shares

$53,754
0.34% of portfolio
Abingworth LLP London, X0

200K
Shares

$36,000
0.02% of portfolio

View Full List

About Molecular Templates, Inc.

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

More about MTEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account